Chidamide in relapsed or refractory peripheral T cell lymphoma: a multicenter real-world study in ChinaYuankai Shi, Jingwen Wang, Lugui Qiu et al.|Journal of Hematology & Oncology|2017Cited by 256
A phase 3 study of rituximab biosimilar HLX01 in patients with diffuse large B-cell lymphomaYuankai Shi, Xin Zhang, Jie Jin et al.|Journal of Hematology & Oncology|2020Cited by 50